- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06515951
Effectiveness of the STANDING Algorithm for the Differential Diagnosis of Vertigo (STANDING-M)
July 20, 2024 updated by: Peiman Nazerian
Diagnostic Accuracy of the STANDING Algorithm for the Differential Diagnosis of Vertigo in the Emergency Department: a Multicenter Study.
Differential diagnosis of vertigo is complex especially in emergency department, nevertheless it is crucial.
The aim of this study is to assess the accuracy of STANDING algorithm for discriminate central from peripheral type of vertigo, identifying more easily the presence of ischemic stroke.
Study Overview
Detailed Description
Vertigo represents a common medical problem which afflicts about 20-30% of the population and it is a frequent cause of abstention from work and disability.
In most cases it is provoked by a benign disease of inner ear, however it can be the main symptom of a more dangerous illness like ischemic or hemorragic stroke, cerebral neoplasm or demyelinating disease.
Indeed, vertigo is the prevailing clinical problem in patients with misdiagnosed ischemic stroke, leading to an increase of mortality in the acute phase of disease.
In the current state, two diagnostic algorithm have been proposed for the evaluation of acute vertigo, named with the acronyms HINTS and STANDING.
The former is characterized by high sensibility and specificity when utilized by a specialist physician, but it is cumbersome to used in emergency department.
Conversely, the latter has been validated exactly in this setting and comprises the evaluation of benign paroxysmal positional vertigo and of upright position.
The aim of this study is to estimate the accuracy of STANDING algorithm in differentiating peripheral vertigo from central from, in particular ischemic stroke, and its potential usefulness in decreasing the use of neuroimaging and specialist consultant.
Study Type
Observational
Enrollment (Actual)
456
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Prato, Italy, 59100
- Nuovo Ospedale di Prato, Medicina d'Urgenza
-
-
Firenze
-
Empoli, Firenze, Italy, 50053
- Azienda USL Toscana Centro, Medicina d'Urgenza e Dipartimento Emergenza e Area Critica
-
-
Lucca
-
Viareggio, Lucca, Italy, 55049
- Ospedale Versilia, Medicina d'Urgenza
-
-
Tuscany
-
Firenze, Tuscany, Italy, 50134
- Azienda Ospedaliera Universitaria Careggi, Medicina d'Urgenza
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Sampling Method
Probability Sample
Study Population
Every adult patient presenting in emergency department with vertigo, dizziness or balance disorder.
Description
Inclusion Criteria:
- patients over 18 years of age.
- patients affected by vertigo, dizziness or balance disorder.
Exclusion Criteria:
- age under 18.
- patients unable to cooperate (with severe dementia or incapable to provide consensus).
- patients affected by disease of cervical spine or any trauma of this part of body that contraindicate the manipulation of neck.
- impractical follow-up.
- dying patient (less three estimated months to live).
- patients with neurologic deficit identified during triage examination (Cincinnati Prehospital stroke scale, CPSS>0) of suffering from another disease that can be the cause of dizziness/balance disorder (e.g. anemia, arrhythmia, hypoglycemia, alcoholic intoxication).
- patients without symptoms at the time of examination.
- patients who deny the participation in the study.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
STANDING group
Consecutive adult patients who access the emergency room due to vertigo / imbalance will be considered eligible for the study.
in this group patients will be evaluated by STANDING protocol
|
The STANDING algorithm is composed by four steps.
The first phase consists in evaluating the presence of spontaneous nystagmus at rest for at least five minutes with and without Frenzel goggles in order to assess if a acute vestibular syndrome is present.
If there is not a spontaneous nystagmus, then positional maneuvers (Pagnini-Mc Cure and Dix-Hallpike) have to be performed.
Otherwise if spontaneous nystagmus is observed, its feature are fundamental to diagnose a central vertigo.
If nystagmus characteristics suggest a peripheral form, the head impulse test is performed by instructing the patient to keep eyes on a fixed target and then turned the head quickly.
An abnormal response is typical of vestibular neuritis.
In any cases after the described maneuvers, the patient must be evaluated when standing up and walking: if this turn out to be impossibile, the test is indicative of central nervous system disease.
|
|
Control group
Consecutive adult patients who access the emergency room due to vertigo / imbalance will be considered eligible for the study.
in this group patients will be evaluated by standard of care
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Accuracy of STANDING algorithm for the diagnosis of types of vertigo.
Time Frame: Thirty days
|
Accuracy (proportion of true positive and negative cases among the total number of cases examined) together with sensitivity, specificity, negative and positive predictive values, negative and positive likelihood ratios of STANDING algorithm performed by emergency physicians to distinguish central and peripheral vertigo.
|
Thirty days
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in the use of neuroimaging
Time Frame: Thirty days
|
Evaluation if the use of STANDING algorithm can reduce the number neuroimaging (a composite of CT of the head and brain MRI) exams performed in patients with suspected central vertigo according to the STANDING algorithm.
|
Thirty days
|
|
Safety of hospital discharge
Time Frame: Thirty days
|
Evaluation if the use of STANDING algorithm allows a safe discharge of patients with diagnosis of benign vertigo.
At 1 month follow-up we evaluate the composite of: number of readmissions for stroke, need for cerebral revasculation procedures, for neurosurgery or all cause death or death for stroke) in patients without suspected central vertigo according to the STANDING algorithm.
|
Thirty days
|
|
Accuracy for diagnosis of stroke
Time Frame: Thirty days
|
Accuracy (proportion of true positive and negative cases of stroke among the total number of cases examined)
|
Thirty days
|
|
Change in the use of specialist consultant
Time Frame: thirty days
|
Evaluation if the use of STANDING algorithm can reduce the number of specialist medical consultations (composite of neurological and ENT consultations) performed in patients with suspected central vertigo according to the STANDING algorithm.
|
thirty days
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Study Chair: Simone Magazzini, MD, Direttore Dipartimento Emergenza Urgenza e Area Critica AUTC
- Study Chair: Maurizio Bartolucci, MD, Direttore Dipartimento Diagnostica per immagini AUTC
- Study Chair: Paola Bartalucci, MD, Medicina d'Urgenza Empoli AUTC
- Study Chair: Claudia Casula, MD, Medicina d'Urgenza Empoli AUTC
- Principal Investigator: Simone Vanni, MD, Direttore SOC Medicina d'Urgenza EMPOLI; Direttore Area della Formazione Dipartimento Emergenza Urgenza e Area Critica AUTC
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
June 9, 2022
Primary Completion (Actual)
June 9, 2023
Study Completion (Actual)
November 1, 2023
Study Registration Dates
First Submitted
May 10, 2023
First Submitted That Met QC Criteria
July 20, 2024
First Posted (Actual)
July 23, 2024
Study Record Updates
Last Update Posted (Actual)
July 23, 2024
Last Update Submitted That Met QC Criteria
July 20, 2024
Last Verified
July 1, 2024
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 11085 (DAIDS ES Registry Number)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Vertigo
-
Dent Neuroscience Research CenterUniversity at BuffaloCompletedMeniere's Disease | Ménière's Vertigo | Vertigo, Intermittent | Vertigo, AuralUnited States
-
Riphah International UniversityCompletedBenign Paroxysmal Positional Vertigo (Disorder)Pakistan
-
Chiang Mai UniversityUnknown
-
Region StockholmKarolinska InstitutetRecruiting
-
Dent Neuroscience Research CenterCures Within Reach; Dent Family FoundationRecruitingMeniere Disease | Ménière's Vertigo | Vertigo, Intermittent | Vertigo, AuralUnited States
-
Universitas Sebelas MaretDexa Medica GroupCompletedBenign Paroxysmal Positional Vertigo (Disorder)Indonesia
-
Chonbuk National UniversityUnknownBenign Paroxysmal Positional Vertigo (BPPV)Korea, Republic of
-
American University of Beirut Medical CenterRecruitingBenign Paroxysmal Positional Vertigo (BPPV)Lebanon
-
Gaziosmanpasa Research and Education HospitalNot yet recruitingDizziness | Vestibular Disorders | Vestibular Function Disorder | Vertigo Benign Positional | Dizziness and Vertigo | Unilateral Peripheral Vestibular Hypofunction
-
Norfolk and Norwich University Hospitals NHS Foundation...Guy's and St Thomas' NHS Foundation Trust; University Hospitals, Leicester; University... and other collaboratorsRecruitingVestibular Migraine | Benign Paroxysmal Positional Vertigo (BPPV) | Ménière's DiseaseUnited Kingdom
Clinical Trials on STANDING algorithm
-
Groupe Hospitalier Paris Saint JosephCompletedEmergencies | Acute Vestibular SyndromeFrance
-
Science and Research Centre KoperUniversity of MichiganRecruitingPain, Acute | Work-Related Condition | Muscle Tone Abnormalities | Sensory DeficitSlovenia
-
University of MinnesotaMayo ClinicCompleted
-
Science and Research Centre KoperUniversity of MichiganUnknownCognitive Change | Aging | Diabete MellitusUnited States
-
Toronto Rehabilitation InstituteOntario Neurotrauma FoundationCompletedSpinal Cord Injury. | Osteoporosis.Canada
-
University of New BrunswickHorizon Health Network; St. Thomas University; Universite de Moncton; Canadian...CompletedFrailty | Physical Disability | Sedentary BehaviorCanada
-
Maastricht UniversityCompletedProblem-Based LearningNetherlands
-
Boston Medical CenterWithdrawnParental/Patient SatisfactionUnited States
-
University of ArizonaWithdrawn
-
IRCCS Policlinico S. DonatoRecruitingHealthy | Cerebral Autoregulation | Autonomic Nervous SystemItaly